Literature DB >> 9194112

Lifetime cost of care for children with human immunodeficiency virus infection.

P L Havens1, B E Cuene, D R Holtgrave.   

Abstract

BACKGROUND: Knowledge of the cost of care for children with HIV infection is necessary to analyze the economic impact of recommendations for universal counseling and voluntary HIV testing of pregnant women.
OBJECTIVES: To estimate the total cost of care for children with HIV infection.
METHODS: We performed a retrospective cohort study of all 88 children with (n = 29) or at risk for (n = 59) perinatally acquired HIV infection cared for at Children's Hospital of Wisconsin between February 2, 1987, and June 1, 1995. Review of medical records for all 29 children with perinatally acquired HIV infection or AIDS identified: date of HIV diagnosis; date of classification into Category N, A, B or C; date of AIDS diagnosis; and date of death or transfer of care. The time each subject remained in each CDC category was calculated and the Kaplan-Meier product-limit method was used to calculate survival time for all patients in each CDC category. Hospital-based inpatient and outpatient charges per patient per month in each CDC category (N, A, B, C and AIDS) were calculated with information from the hospital financial services database, and lifetime hospital-based inpatient and outpatient charges were estimated as the sum of the charges for each category. From that, total charges were calculated assuming that hospital-based charges were 83% of total charges.
RESULTS: Based on a median survival time of 120 months, the mean lifetime charges for hospital-based care for children with HIV infection was $408307 (estimates ranged from $172217 to $498539). If hospital-based care represents 83% of the total charges for care of children with HIV infection, then mean total lifetime charges for care of children with HIV infection were $491936 ($207490 to $600649).
CONCLUSIONS: The care of children with HIV infections is expensive. This information may be useful in planning for care programs and for analyzing the economic impact of recommendations for universal counseling and voluntary HIV testing of pregnant women.

Entities:  

Mesh:

Year:  1997        PMID: 9194112     DOI: 10.1097/00006454-199706000-00012

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN: 0891-3668            Impact factor:   2.129


  6 in total

1.  The communicable disease impact of eliminating publicly funded prenatal care for undocumented immigrants.

Authors:  H Kuiper; G A Richwald; H Rotblatt; S Asch
Journal:  Matern Child Health J       Date:  1999-03

2.  Use and cost of hospital and community service provision for children with HIV infection at an English HIV referral centre.

Authors:  E J Beck; S Mandalia; R Griffith; J Beecham; M D Walters; M Boulton; D L Miller
Journal:  Pharmacoeconomics       Date:  2000-01       Impact factor: 4.981

Review 3.  The cost of HIV treatment and care. A global review.

Authors:  E J Beck; A H Miners; K Tolley
Journal:  Pharmacoeconomics       Date:  2001-01       Impact factor: 4.981

Review 4.  Economic issues in the prevention of vertical transmission of HIV.

Authors:  A E Ades; J Ratcliffe; D M Gibb; M J Sculpher
Journal:  Pharmacoeconomics       Date:  2000-07       Impact factor: 4.981

5.  The cost-effectiveness of directly observed highly-active antiretroviral therapy in the third trimester in HIV-infected pregnant women.

Authors:  Caitlin J McCabe; Sue J Goldie; David N Fisman
Journal:  PLoS One       Date:  2010-04-13       Impact factor: 3.240

6.  Perinatal HIV transmission and the cost-effectiveness of screening at 14 weeks gestation, at the onset of labour and the rapid testing of infants.

Authors:  Belinda Udeh; Chiedozie Udeh; Nicholas Graves
Journal:  BMC Infect Dis       Date:  2008-12-31       Impact factor: 3.090

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.